Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-19T00:07:34.424Z Has data issue: false hasContentIssue false

Chapter 14 - Parathyroid gland

from Section III - Anatomical endocrine pathology

Published online by Cambridge University Press:  13 April 2017

By
Lori A. Erickson
Edited by
Ozgur Mete  and
Sylvia L. Asa
Ozgur Mete
Affiliation:
University of Toronto
Sylvia L. Asa
Affiliation:
University of Toronto
Get access
Type
Chapter
Information
Endocrine Pathology , pp. 573 - 587
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rosai, J, DeLellis, RA. Atlas of Tumor Pathology, 4th Series, Fascicle 21: Tumors of the Thyroid and Parathyroid Glands Bethesda, MD: ARP Press, 2015.Google Scholar
Lappas, D, Noussios, G, Anagnostis, P, Adamidou, F, Chatzigeorgiou, A, Skandalakis, P. Location, number and morphology of parathyroid glands: results from a large anatomical series. Anat Sci Int 87:160–164, 2012.Google Scholar
Akersstrom, G, Malmaeus, J, Berstrom, R. Surgical anatomy of human parathyroid glands. Surgery 95:14–21, 1984.Google Scholar
Phitayakorn, R, McHenry, CR. Incidence and location of ectopic abnormal parathyroid glands. Am J Surg 191;418–423, 2006.Google Scholar
Noussios, G, Anagnostis, P, Natsis, K. Ectopic parathyroid glands and their anatomical, clinical and surgical implications. Exp Clin Endocrinol Diabetes 120:604–610, 2012.Google Scholar
Uchino, S, Noguchi, S, Sato, M, Yamashita, H, Watanabe, S, Murakami, T, Toda, M, Ohshima, A, Futata, T, Mizukoshi, T, Koike, E, Takatsu, K, Terao, K, Wakiya, S, Nagatomo, M, Adachi, M. Screening of the MEN1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 60:5553–5557, 2000.Google Scholar
Chandrasekharappa, SC, Guru, SC, Manickam, P, Olufemi, SE, Collins, FS, Emmert-Buck, MR, Debelenko, LV, Zhuang, Z, Lubensky, IA, Liotta, LA, Crabtree, JS, Wang, Y, Roe, BA, Weisemann, J, Boguski, MS, Agarwal, SK, Kester, MB, Kim, YS, Heppner, C, Dong, Q, Spiegel, AM, Burns, AL, Marx, SJ. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404–407, 1997.CrossRefGoogle ScholarPubMed
Romei, C, Pardi, E, Cetani, F, Elisei, R. Genetic and clinical features of multiple endocrine neoplasia types 1 and 2. J Oncol 1–15, 2012.Google Scholar
Marx, SJ, Agarwal, SK, Kester, MB, Heppner, C, Kim, YS, Skarulis, MC, James, LA, Goldsmith, PK, Saggar, SK, Park, SY, Spiegel, AM, Burns, AL, Debelenko, LV, Zhuang, Z, Lubensky, IA, Liotta, LA, Emmert-Buck, MR, Guru, SC, Manickam, P, Crabtree, J, Erdos, MR, Collins, FS, Chandrasekharappa, SC. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog Horm Res 54:397–438; discussion 438–439, 1999.Google ScholarPubMed
Agarwal, SK, Lee Burns, A, Sukhodolets, KE, Kennedy, PA, Obungu, VH, Hickman, AB, Mullendore, ME, Whitten, I, Skarulis, MC, Simonds, WF, Mateo, C, Crabtree, JS, Scacheri, PC, Ji, Y, Novotny, EA, Garrett-Beal, L, Ward, JM, Libutti, SK, Richard Alexander, H, Cerrato, A, Parisi, MJ, Santa Anna, AS, Oliver, B, Chandrasekharappa, SC, Collins, FS, Spiegel, AM, Marx, SJ. Molecular pathology of the MEN1 gene. Ann N Y Acad Sci 1014:189–198, 2004.Google Scholar
Arnold, A, Shattuck, TM, Mallya, SM, Krebs, LJ, Costa, J, Gallagher, J, Wild, Y, Saucier, K. Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res 17(suppl 2):N30–N36, 2002.Google Scholar
Friedman, E, Sakaguchi, K, Bale, AE, Falchetti, A, Streeten, E, Zimering, MB, Weinstein, LS, McBride, WO, Nakamura, Y, Brandi, ML, Norton, JA, Aurbach, GD, Spiegel, AM,Marx, SJ. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321:213–218, 1989.Google Scholar
Agah, A, Carpenter, R, Bhattacharya, S, Edmonson, SJ, Carlsen, E, Monson, JP. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognized entity. J Endocrinol Invest 2007;30:145–149.CrossRefGoogle Scholar
del Pozo, C, Garcia-Pascual, L, Balsells, M, Barahona, MJ, Veloso, E, González, C, Anglada-Barceló, J. Parathyroid carcinoma in multiple endocrine neoplasia type 1. Case report and review of the literature. Hormones 10:326–331, 2011.Google Scholar
Lemos, MC, Thakker, RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22–32, 2008.Google Scholar
Scarpelli, D, D'Aloiso, L, Arturi, F, Scillitani, A, Presta, I, Bisceglia, M, Cristofaro, C, Russo, D, Filetti, S. Novel somatic MEN1 gene alterations in sporadic primary hyperparathyroidism and correlation with clinical characteristics. J Endocrinol Invest 27:1015–1021, 2004.Google Scholar
Haven, CJ, van Puijenbroek, M, Tan, MH, Teh, BT, Fleuren, GJ, van Wezel, T, Morreau, H. Identification of MEN1 and HRPT2 somatic mutations in paraffin-embedded (sporadic) parathyroid carcinomas. Clin Endocrinol (Oxf) 67:370–376, 2007.Google Scholar
Haven, CJ, Howell, VM, Eilers, PH, Dunne, R, Takahashi, M, van Puijenbroek, M, Furge, K, Kievit, J, Tan, MH, Fleuren, GJ, Robinson, BG, Delbridge, LW, Philips, J, Nelson, AE, Krause, U, Dralle, H, Hoang-Vu, C, Gimm, O, Morreau, H, Marsh, DJ, Teh, BT. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res 64:7405–7411, 2004.Google Scholar
Alvelos, MI, Vinagre, J, Fonseca, E, et al. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism. Eur J Endocrinol 168:119–128, 2013.Google Scholar
Oishi, S, Sato, T, Takiguchi-Shirahama, S, Nakamura, Y. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome). Endocr J 42:527–536, 1995.CrossRefGoogle ScholarPubMed
Machens, A, Dralle, H. Genotype–phenotype based surgical concept of hereditary medullary thyroid carcinoma. World J Surg 31:957–968, 2007.Google Scholar
Eng, C, Clayton, D, Schuffenecker, I, Lenoir, G, Cote, G, Gagel, RF, van Amstel, HK, Lips, CJ, Nishisho, I, Takai, SI, Marsh, DJ, Robinson, BG, Frank-Raue, K, Raue, F, Xue, F, Noll, WW, Romei, C, Pacini, F, Fink, M, Niederle, B, Zedenius, J, Nordenskjold, M, Komminoth, P, Hendy, GN, Mulligan, LM:The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575–1579, 1996.CrossRefGoogle ScholarPubMed
Jenkins, PJ, Satta, MA, Simmgen, M, Drake, WM, Williamson, C, Lowe, DG, Britton, K, Chew, SL, Thakker, RV, Besser, GM. Metastatic parathyroid carcinoma in MEN2A syndrome. Clin Endocrinol (Oxf) 47:747–751, 1997.Google Scholar
Kimura, T, Yoshimoto, K, Tanaka, C, Ohkura, T, Iwahana, H, Miyauchi, A, Sano, T, Itakura, M. Obvious mRNA and protein expression but absence of mutations of the RET proto-oncogene in parathyroid tumors. Eur J Endocrinol 134:314–319, 1996.Google Scholar
Pellegata, NS, Quintanilla-Martinez, L, Siggelkow, H, et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia in rats and humans. Proc Natl Acad Sci USA 103; 15558–15563, 2006.CrossRefGoogle Scholar
Malanga, D, De Gisi, S, Riccardi, M, Scrima, M, De Marco, C, Robledo, M, Viglietto, G. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype. Eur J Endocrinol 166:551–560, 2012.Google Scholar
Hemmer, S, Wasenius, VM, Haglund, C, Zhu, Y, Knuutila, S, Franssila, K, Joensuu, H. Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Am J Pathol 158:1355–1362, 2001.CrossRefGoogle ScholarPubMed
Hsi, ED, Zukerberg, LR, Yang, WI, Arnold, A. Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 81:1736–1739, 1996.Google Scholar
Erickson, LA, Jalal, SM, Harwood, A, Shearer, B, Jin, L, Lloyd, RV. Analysis of parathyroid neoplasms by interphase fluorescence in situ hybridization. Am J Surg Pathol 28:578–584, 2004.CrossRefGoogle ScholarPubMed
Teh, BT, Farnebo, F, Twigg, S, Hoog, A, Kytola, S, Korpi-Hyovalti, E, Wong, FK, Nordenstrom, J, Grimelius, L, Sandelin, K, Robinson, B, Farnebo, LO, Larsson, C. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab 83:2114–2120, 1998.Google Scholar
Carpten, JD, Robbins, CM, Villablanca, A, Forsberg, L, Presciuttini, S, Bailey-Wilson, J, Simonds, WF, Gillanders, EM, Kennedy, AM, Chen, JD, Agarwal, SK, Sood, R, Jones, MP, Moses, TY, Haven, C, Petillo, D, Leotlela, PD, Harding, B, Cameron, D, Pannett, AA, Hoog, A, Heath, H 3rd, James-Newton, LA, Robinson, B, Zarbo, RJ, Cavaco, BM, Wassif, W, Perrier, ND, Rosen, IB, Kristoffersson, U, Turnpenny, PD, Farnebo, LO, Besser, GM, Jackson, CE, Morreau, H, Trent, JM, Thakker, RV, Marx, SJ, Teh, BT, Larsson, C, Hobbs, MR. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676–680, 2002.Google Scholar
Marx, SJ, Simonds, WF, Agarwal, SK, Burns, AL, Weinstein, LS, Cochran, C, Chandrasekharappa, SC, Collins, FS. Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Miner Res 17(suppl 2):N37–N43, 2002.Google Scholar
Howell, VM, Haven, CJ, Kahnoski, K, Khoo, SK, Petillo, D, Chen, J, Fleuren, GJ, Robinson, BG, Delbridge, LW, Philips, J, Nelson, AE, Krause, U, Hammje, K, Dralle, H, Hoang-Vu, C, Gimm, O, Marsh, DJ, Morreau, H, Teh, BT. HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657–663, 2003.Google Scholar
Shattuck, TM, Valimaki, S, Obara, T, Gaz, RD, Clark, OH, Shoback, D, Wierman, ME, Tojo, K, Robbins, CM, Carpten, JD, Farnebo, LO, Larsson, C, Arnold, A. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722–1729, 2003.Google Scholar
Krebs, LJ, Shattuck, TM, Arnold, A. HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab 90:5015–5017, 2005.CrossRefGoogle ScholarPubMed
Warner, JV, Nyholt, DR, Busfield, F, Epstein, M, Burgess, J, Stranks, S, Hill, P, Perry-Keene, D, Learoyd, D, Robinson, B, Teh, BT, Prins, JB, Cardinal, JW. Familial isolated hyperparathyroidism is linked to a 1.7 Mb region on chromosome 2p13.3-14. J Med Genet 43:e12, 2006.Google Scholar
Wassif, WS, Moniz, CF, Friedman, E, Wong, S, Weber, G, Nordenskjold, M, Peters, TJ, Larsson, C. Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab 77:1485–1489, 1993.Google Scholar
Simonds, WF, Robbins, CM, Agarwal, SK, Hendy, GN, Carpten, JD, Marx, SJ. Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89:96–102, 2004.CrossRefGoogle ScholarPubMed
Aida, K, Koishi, S, Inoue, M, Nakazato, M, Tawata, M, Onaya, T. Familial hypocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene. J Clin Endocrinol Metab 80:2594–2598, 1995.Google ScholarPubMed
Marx, SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 343:1863–1875, 2000.Google Scholar
Hellman, P, Carling, T, Rask, L, Akerstrom, G. Pathophysiology of primary hyperparathyroidism. Histol Histopathol 15:619–627, 2000.Google Scholar
Cole, DE, Janicic, N, Salisbury, SR, Hendy, GN. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 71:202–210, 1997.Google Scholar
Kifor, O, Moore, FD Jr., Delaney, M, Garber, J, Hendy, GN, Butters, R, Gao, P, Cantor, TL, Kifor, I, Brown, EM, Wysolmerski, J. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 88:60–72, 2003.CrossRefGoogle ScholarPubMed
Agarwal, SK, Schrock, E, Kester, MB, Burns, AL, Heffess, CS, Ried, T, Marx, SJ. Comparative genomic hybridization analysis of human parathyroid tumors. Cancer Genet Cytogenet 106:30–36, 1998.Google Scholar
Palanisamy, N, Imanishi, Y, Rao, PH, Tahara, H, Chaganti, RS, Arnold, A. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab 83:1766–1770, 1998.Google Scholar
Garcia, JL, Tardio, JC, Gutierrez, NC, Gonzalez, MB, Polo, JR, Hernandez, JM, Menarguez, J. Chromosomal imbalances identified by comparative genomic hybridization in sporadic parathyroid adenomas. Eur J Endocrinol 146:209–213, 2002.CrossRefGoogle ScholarPubMed
Cryns, VL, Rubio, MP, Thor, AD, Louis, DN, Arnold, A. p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 78:1320–1324, 1994.Google Scholar
Cryns, VL, Thor, A, Xu, HJ, Hu, SX, Wierman, ME, Vickery, AL Jr., Benedict, WF, Arnold, A. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 330:757–761, 1994.Google Scholar
Samander, EH, Arnold, A. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyhroid adenomas. J Clin Endocrinol Metab 91:5019–5021, 2006.Google Scholar
Parvari, R, Hershkovitz, E, Grossman, N, Gorodischer, R, Loeys, B, Zecic, A, Mortier, G, Gregory, S, Sharony, R, Kambouris, M, Sakati, N, Meyer, BF, Al Aqeel, AI, Al Humaidan, AK, Al Zanhrani, F, Al Swaid, A, Al Othman, J, Diaz, GA, Weiner, R, Khan, KT, Gordon, R, Gelb, BD. Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome. Nat Genet 32:448–452, 2002.Google Scholar
Goswami, R, Brown, EM, Kochupillai, N, Gupta, N, Rani, R, Kifor, O, Chattopadhyay, N. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol 150:9–18, 2004.Google Scholar
Heath, H. 3rd. Primary hyperparathyroidism: recent advances in pathogenesis, diagnosis, and management. Adv Intern Med 37:275–293, 1992.Google ScholarPubMed
Brandi, ML, Gagel, RF, Angeli, A, Bilezikian, JP, Beck-Peccoz, P, Bordi, C, Conte-Devolx, B, Falchetti, A, Gheri, RG, Libroia, A, Lips, CJ, Lombardi, G, Mannelli, M, Pacini, F, Ponder, BA, Raue, F, Skogseid, B, Tamburrano, G, Thakker, RV, Thompson, NW, Tomassetti, P, Tonelli, F, Wells, SA Jr., Marx, SJ. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671, 2001.Google Scholar
Castleman, B, Roth, SI. Atlas of Tumor Pathology, 2nd Series, Fascicle 14: Tumors of the Parathyroid Gland. Washington DC: Armed Forces Institute of Pathology, 2015.Google Scholar
Harach, HR, Jasani, B. Parathyroid hyperplasia in multiple endocrine neoplasia type 1: a pathological and immunohistochemical reappraisal. Histopathology 20:305–313, 1991.Google Scholar
Tominaga, Y, Grimelius, L, Johansson, H, Rudberg, C, Johansson, H, Ljunghall, S, Bergstrom, R, Rastad, J, Akerstrom, G. Histological and clinical features of non-familial primary parathyroid hyperplasia. Pathol Res Pract 188:115–122, 1992.Google Scholar
DeLellis, RA. Parathyroid tumors and related disorders. Mod Pathol 24:578–593, 2011.Google Scholar
Snover, D, Foucar, K. Mitotic activity in benign parathyroid disease. Am J Clin Pathol 75:345–347, 1981.Google Scholar
Albright, F, Bloomberg, E, Castleman, B, Churchill, ED. Hyperparathyroidism due to diffuse hyperplasia of all parathyroid glands rather than adenoma of one. Clinical studies on three such cases. Arch Int Med 54:35–329, 1934.Google Scholar
Erickson, LA, Jin, L, Wollan, P, Thompson, GB, van Heerden, JA, Lloyd, RV. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Am J Surg Pathol 23:288–295, 1999.Google Scholar
Ellard, S, Hattersley, AT, Brewer, CM, Vaidya, B. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing. Clin Endocrinol (Oxf) 62:169–175, 2005.Google Scholar
Klein, RD, Salih, S, Bessoni, J, Bale, AE. Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory. Genet Med 7:131–138, 2005.Google Scholar
Goudet, P, Bonithon-Kopp, C, Murat, A, Ruszniewski, P, Niccoli, P, Ménégaux, F, Chabrier, G, Borson-Chazot, F, Tabarin, A, Bouchard, P, Cadiot, G, Beckers, A, Guilhem, I, Chabre, O, Caron, P, Du Boullay, H, Verges, B, Cardot-Bauters, C. Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines. Eur J Endocrinol 165:97–105, 2011.Google Scholar
Lips, CJ, Dreijerink, KM, Hoppener, JW. Variable clinical expression in patients with germline MEN1 disease gene mutation: clues to genotype–phenotype correlation. Clinics 67(suppl):49–56, 2012.Google Scholar
Cope, O, Keynes, M, Roth, SI, Castleman, B. Primary chief cell hyperplasia of the parathyroid glands: a new entity in the surgery of hyperparathyroidism. Ann Surg 148:375–388, 1958.Google Scholar
Stojadinovic, A, Hoos, A, Nissan, A, Dudas, ME, Cordon-Cardo, C, Shaha, AR, Brennan, MF, Singh, B, Ghossein, RA. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol 34:54–64, 2003.Google Scholar
Gill, AJ, Clarkson, A, Gimm, O, Keil, J, Dralle, H, Howell, VM, Marsh, DJ. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 30:1140–1149, 2006.Google Scholar
Tominaga, Y, Tsuzuki, T, Matsuoka, S, Uno, N, Sato, T, Shimabukuro, S, Goto, N, Nagasaka, T, Uchida, K. Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease. World J Surg 32:815–821, 2008.Google Scholar
Wermers, RA, Khosia, S, Atkinson, EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on changing epidemiology of the disease. J Bone Miner Res 21:171–177, 2006.Google Scholar
Russ, JE, Scanlon, EF, Sener, SF. Parathyroid adenomas following irradiation. Cancer 43:1078–1083, 1979.Google Scholar
Castleman, B, Mallory, TB. The pathology of the parathyroid gland in hyperparathyroidism: a study of 25 cases. Am J Pathol 11:1–72, 1935.Google Scholar
Bedetti, CD, Dekker, A, Watson, CG. Functioning oxyphil adenoma of the parathyroid gland. A clinicopathologic study of ten patients with hyperparathyroidism. Hum Pathol 15:1121–1126, 1984.Google Scholar
Erickson, LA, Jin, L, Papotti, M, Lloyd, RV. Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol 26:344–349, 2002.Google Scholar
Chow, LS, Erickson, LA, Abu-Lebdeh, HS, Wermers, RA; Parathyroid lipoadenomas: a rare cause of primary hyperparathyroidism. Endocr Pract 12:131–136, 2006.Google Scholar
Abbona, CG, Papotti, M, Gasparri, G, Gasparri, G, Bussolati, G. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 26:135–138, 1995.Google Scholar
Lloyd, RV, Carney, JA, Ferreiro, JA, Jin, L, Thompson, GB, Van Heerden, JA, Grant, CS, Wollan, PC. Immunohistochemical analysis of the cell cycle associated antigens Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas. Endocr Pathol 6:279–287, 1995.Google Scholar
Vargas, MP, Vargas, HI, Keiner, DE, Merino, MJ. The role of prognostic markers (MIB-1, RB and BCL-2) in the diagnosis of parathyroid tumors. Mod Pathol 10:12–17, 1997.Google Scholar
Bergero, N, DePompa, R, Sacerdote, C, Gasparri, G, Volante, M, Bussolati, G, Papotti, M. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol 36:908–914, 2005.Google Scholar
Howell, VM, Gill, A, Clarkson, A, Nelson, AE, Dunne, R, Delbridge, LW, Robinson, BG, The, BT, Gimm, O, Marsh, DJ. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94:343–441, 2009.Google Scholar
DeLellis, RA. Parathyroid carcinoma: an overview. Adv Anat Pathol 12:53–61, 2005.Google Scholar
Giessler, GA, Beech, DJ. Nonfunctional parathyroid carcinoma. J Natl Med Assoc 93:251–255, 2001.Google Scholar
Busaidy, NL, Jimenez, C, Habra, MA, Schultz, PN, El-Naggar, AK, Clayman, GL, Asper, JA, Diaz, EM Jr., Evans, DB, Gagel, RF, Garden, A, Hoff, AO, Lee, JE, Morrison, WH, Rosenthal, DI, Sherman, SI, Sturgis, EM, Waguespack, SG, Weber, RS, Wirfel, K, Vassilopoulou-Sellin, R. Parathyroid carcinoma: a 22-year experience. Head Neck 26:716–726, 2004.Google Scholar
Schantz, A, Castleman, B. Parathyroid carcinoma: a study of 70 cases. Cancer 31:600–605, 1973.Google Scholar
Wynne, AG, van Heerden, J, Carney, JA, Fitzpatrick, LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine 71:197–205, 1992.Google Scholar
Hundahl, SA, Fleming, ID, Fremgen, AM and Menck, HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the US between 1985–1995: a National Cancer Data Base report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86,538–544, 1999.Google Scholar
Mangray, S, DeLellis, RA. Parafibromin as a tool for the diagnosis of parathyroid tumors [letter to the editor]. Adv Anat Pathol 15:179, 2008.Google Scholar
Juhlin, C, Larsson, C, Yakoleva, T, Leibiger, I, Leibiger, B, Alimov, A, Weber, G, Hoog, A, Villablanca, A. Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer 13:509–523, 2006.Google Scholar
Talat, N, Schulte, K. Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol 17;2156–2174, 2010.Google Scholar
Schulte, K.M. and Talat, N. Diagnosis and management of parathyroid cancer. Nat Rev Endocrinol 8; 612–622, 2012.Google Scholar
Lee, PK, Jarosek, SL, Virnig, BA, Evasovich, M, Tuttle, TM. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109; 1736–1741, 2007.CrossRefGoogle ScholarPubMed
Sandelin, K, Auer, G, Bondeson, L, Grimelius, L, Farnebo, LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg 16:724–731, 1992.Google Scholar
Munson, ND, Foote, RL, Northcutt, RC, Tiegs, RD, Fitzpatrick, LA, Grant, CS, van Heerden, JA, Thompson, GB, Lloyd, RV. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer 98:2378–2384, 2003.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×